US Stock MarketDetailed Quotes

CMPX Compass Therapeutics

Watchlist
  • 1.370
  • -0.050-3.52%
Trading Dec 19 09:50 ET
188.50MMarket Cap-3.91P/E (TTM)

Compass Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Compass Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q2850.000K / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q2850.000K / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Compass Therapeutics Earnings Reports

  • Compass Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 12:23 ET

  • Compass Therapeutics | 8-K: Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update

    Nov 12 09:30 ET

  • Compass Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 08:05 ET

  • Compass Therapeutics | 8-K: Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update

    Aug 12 08:05 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    YETI Holdings
    YETI
    +1.89%
    eBay
    EBAY
    +1.56%
    Precision Drilling
    PDS
    +1.46%
    Dorian LPG
    LPG
    +1.07%
    Halozyme Therapeutics
    HALO
    +1.05%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data